Quality & Patient Safety

USP updates target patient safety concerns within compounding pharmaceuticals

Patient Safety Monitor, January 1, 2016

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Patient Safety Monitor.

Five years after pharmaceutical experts began reviewing changes to sterile preparation requirements for pharmaceutical compounding, the U.S. Pharmacopeial Convention (USP) has released proposed regulatory updates aimed at preventing patient harm.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Patient Safety Monitor.

Most Popular